Edition:
United Kingdom

Bellerophon Therapeutics Inc (BLPH.OQ)

BLPH.OQ on NASDAQ Stock Exchange Global Market

0.65USD
18 Apr 2019
Change (% chg)

$0.01 (+1.71%)
Prev Close
$0.64
Open
$0.67
Day's High
$0.68
Day's Low
$0.64
Volume
22,213
Avg. Vol
77,739
52-wk High
$3.30
52-wk Low
$0.47

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Dec '18 0.00 -0.016
Sep '18 0.00 0.172
Jun '18 0.00 -0.200
Mar '18 0.00 0.057
FY 2017 Dec '17 0.00 -0.437
Sep '17 0.00 -0.217
Jun '17 0.00 -0.117
Mar '17 0.00 -0.599
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Year Ending Dec-19 2 0.00 0.00 0.00 0.00
Year Ending Dec-20 2 4.32 8.65 0.00 35.56
Earnings (per share)
Year Ending Dec-19 2 -0.49 -0.46 -0.52 -0.60
Year Ending Dec-20 2 -0.40 -0.38 -0.41 -0.22
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) 51.83 103.27 57.80
P/E High - Last 5 Yrs. 18.53 164.39 56.06
P/E Low - Last 5 Yrs. 18.53 52.66 28.61
Beta -0.01 1.12 0.93
Price to Sales (TTM) -- 45.66 9.15
Price to Book (MRQ) 9.91 12.64 4.46
Price to Tangible Book (MRQ) 11.63 17.91 7.62
Price to Cash Flow (TTM) 14.12 68.67 40.14
% Owned Institutions -- 0.00 0.00

Dividends

  Company industry sector
Dividend Yield -- 0.10 1.54
Dividend Yield - 5 Year Avg -- 0.05 0.70
Dividend 5 Year Growth Rate -- 0.75 2.99
Payout Ratio(TTM) 0.00 8.79 21.84

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 25.01 9.34
Sales (TTM) vs TTM 1 Yr. Ago -- 70.93 8.40
Sales - 5 Yr. Growth Rate -- 33.13 10.97
EPS (MRQ) vs Qtr. 1 Yr. Ago 96.38 -92.89 108.58
EPS (TTM) vs TTM 1 Yr. Ago 100.92 -- --
EPS - 5 Yr. Growth Rate -- 21.70 6.90
Capital Spending - 5 Yr. Growth Rate -- 25.75 7.55

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.72 2.67
Current Ratio (MRQ) 2.31 3.61 3.64
LT Debt to Equity (MRQ) 0.00 7.28 13.32
Total Debt to Equity (MRQ) 0.00 20.11 17.00
Interest Coverage (TTM) -0.81 8.38 27.17

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 23.39 50.39
Gross Margin - 5 Yr. Avg. -- 59.67 50.83
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -14.57 15.70
Operating Margin (TTM) -- -117.15 3.07
Operating Margin - 5 Yr. Avg. -- -30.23 11.04
Pre-Tax Margin (TTM) -- -117.60 2.34
Pre-Tax Margin - 5 Yr. Avg. -- -32.86 16.58
Net Profit Margin (TTM) -- -123.95 -1.58
Net Profit Margin - 5 Yr. Avg. -- -37.92 11.58
Effective Tax Rate (TTM) -- 19.85 22.81
Effective Tax Rate - 5 Yr. Avg. -- 19.62 23.89

Efficiency

  Company industry sector
Revenue/Employee (TTM) 0 8,759,241 777,453,280
Net Income/Employee (TTM) 165,529 2,000,017 89,549,931
Receivable Turnover (TTM) -- 2.40 5.24
Inventory Turnover (TTM) -- 2.31 3.67
Asset Turnover (TTM) 0.00 0.32 0.81

Management Effectiveness

  Company industry sector
Return on Assets (TTM) 10.20 6.23 9.57
Return on Assets - 5 Yr. Avg. -121.86 6.13 10.52
Return on Investment (TTM) 13.88 7.81 11.82
Return on Investment - 5 Yr. Avg. -170.94 8.02 13.42
Return on Equity (TTM) 445.96 7.87 12.64
Return on Equity - 5 Yr. Avg. -290.05 9.08 14.89
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % 103.07 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Bellerophon Therapeutics Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -10.82 -12.36 58 56
13 Week -28.07 -34.73 27 49
26 Week -35.54 -38.57 47 4
52 Week -68.55 -70.68 29 7
YTD -18.77 -29.90 33 7
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 47.62%
# of Holders: 28
Total Shares Held: 32,813,299
3 Mo. Net Change: -21,186
# New Positions: 0
# Closed Positions: 0
# Increased Positions: 0
# Reduced Positions: 2
# Net Buyers: -2
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.